Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
1.4000
+0.0200 (1.45%)
Rani Therapeutics Holdings Inc. is a biopharmaceutical company focused on developing innovative oral therapies for the delivery of biologics, such as peptides and proteins, which traditionally require injection for administration
The company’s proprietary RaniPill platform utilizes a novel approach to encapsulate and deliver these treatments orally, aiming to enhance patient compliance and accessibility in the administration of complex medications. By combining advanced engineering with pharmaceutical expertise, Rani Therapeutics is exploring solutions that could revolutionize the landscape of therapeutic delivery, making it more patient-friendly.
| Previous Close | 1.380 |
|---|---|
| Open | 1.420 |
| Bid | 1.400 |
| Ask | 1.410 |
| Day's Range | 1.390 - 1.430 |
| 52 Week Range | 1.240 - 8.750 |
| Volume | 32,196 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 235,323 |
